Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 11 of 11 entries
View as:

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).

Phase: N/A Priority: Normal
NCT ID: NCT03583372 Org: User:
Start: 06/14/18 End: 07/25/19 Due: 07/25/20

A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)

Phase: N/A Priority: Normal
NCT ID: NCT03492281 Org: User:
Start: 03/26/18 End: 02/04/19 Due: 02/04/20

Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT04103450 Org: User:
Start: 09/19/19 End: 07/29/22 Due: 07/29/23

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03806127 Org: User:
Start: 12/31/18 End: 10/06/20 Due: 10/06/21

Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED

Phase: N/A Priority: Normal
NCT ID: NCT02713789 Org: User:
Start: 04/30/15 End: 08/24/17 Due: 08/24/18

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Phase: N/A Priority: Normal
NCT ID: NCT03902080 Org: User:
Start: 03/26/19 End: 06/15/23 Due: 06/15/24

Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

Phase: N/A Priority: Normal
NCT ID: NCT00495053 Org: User:
Start: 04/30/07 End: 11/30/09 Due: 11/30/10

Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)

Phase: N/A Priority: Normal
NCT ID: NCT05067478 Org: User:
Start: 10/28/21 End: 07/26/24 Due: 07/26/25

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Phase: N/A Priority: Normal
NCT ID: NCT05491525 Org: User:
Start: 10/12/22 End: 09/30/27 Due: 09/30/28

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT04211831 Org: User:
Start: 12/16/19 End: 07/20/22 Due: 07/20/23

Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer

Phase: N/A Priority: Normal
NCT ID: NCT01870037 Org: User:
Start: 01/31/13 End: 02/17/18 Due: 02/17/19